On November 4, 2019, Wright Medical announced that it had reached a definitive agreement to be purchased by Stryker with the deal expected to close in 2H20
The 3Q19 was the second consecutive quarter of growth deceleration for Wright Medical
The company has recently faced severe disruption to its legacy Cartiva sales distributors, as well as talent retention challenges with smaller competitors increasingly penetrating Wright’s core foot and ankle business
ORTHOWORLD projects Wright Medical full year 2019 revenue of $899.6 million, +7.6% vs. 2018
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
3Q19
3Q18
$ Chg
% Chg
Joint Reconstruction Extremities
$106.7
$94.0
$12.7
13.5%
Trauma
$74.2
$68.1
$6.1
8.9%
Sports Medicine
$4.4
$4.8
($0.4)
(8.9%)
Orthobiologics
$27.2
$27.2
$0.0
0%
Total
$212.4
$194.1
$18.3
9.4%
9Mo 19
9Mo 18
$ Chg
% Chg
Joint Reconstruction Extremities
$338.7
$291.7
$47.0
16.1%
Trauma
$235.4
$214.3
$21.1
9.8%
Sports Medicine
$14.0
$14.6
($0.7)
(4.6%)
Orthobiologics
$84.3
$77.4
$6.9
8.9%
Total
$672.3
$598.0
$74.3
12.4%
Geographic Sales
3Q19
3Q18
$ Chg
% Chg
US
$162.2
$145.6
$16.7
11.4%
Ex-US
$50.2
$48.5
$1.7
3.4%
EMEA
$35.1
$33.7
$1.4
4.2%
Asia Pacific
$10.5
$10.2
$0.3
3.4%
Rest of World
$4.5
$4.6
($0.1)
(2%)
Total
$212.4
$194.1
$18.3
9.4%
Earnings
Amt
% of Sales
Sales
$212.4
Cost of Sales
($44.4)
20.9%
General and Admin
($152.8)
71.9%
R & D
($18.0)
8.5%
Other
($41.0)
19.3%
Net Earnings
($43.8)
(20.6%)
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
On November 4, 2019, Wright Medical announced that it had reached a definitive agreement to be purchased by Stryker with the deal expected to close in 2H20 The 3Q19 was the second consecutive quarter of growth deceleration for Wright Medical The company...
On November 4, 2019, Wright Medical announced that it had reached a definitive agreement to be purchased by Stryker with the deal expected to close in 2H20
The 3Q19 was the second consecutive quarter of growth deceleration for Wright Medical
The company has recently faced severe disruption to its legacy Cartiva sales distributors, as well as talent retention challenges with smaller competitors increasingly penetrating Wright’s core foot and ankle business
ORTHOWORLD projects Wright Medical full year 2019 revenue of $899.6 million, +7.6% vs. 2018
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
3Q19
3Q18
$ Chg
% Chg
Joint Reconstruction Extremities
$106.7
$94.0
$12.7
13.5%
Trauma
$74.2
$68.1
$6.1
8.9%
Sports Medicine
$4.4
$4.8
($0.4)
(8.9%)
Orthobiologics
$27.2
$27.2
$0.0
0%
Total
$212.4
$194.1
$18.3
9.4%
9Mo 19
9Mo 18
$ Chg
% Chg
Joint Reconstruction Extremities
$338.7
$291.7
$47.0
16.1%
Trauma
$235.4
$214.3
$21.1
9.8%
Sports Medicine
$14.0
$14.6
($0.7)
(4.6%)
Orthobiologics
$84.3
$77.4
$6.9
8.9%
Total
$672.3
$598.0
$74.3
12.4%
Geographic Sales
3Q19
3Q18
$ Chg
% Chg
US
$162.2
$145.6
$16.7
11.4%
Ex-US
$50.2
$48.5
$1.7
3.4%
EMEA
$35.1
$33.7
$1.4
4.2%
Asia Pacific
$10.5
$10.2
$0.3
3.4%
Rest of World
$4.5
$4.6
($0.1)
(2%)
Total
$212.4
$194.1
$18.3
9.4%
Earnings
Amt
% of Sales
Sales
$212.4
Cost of Sales
($44.4)
20.9%
General and Admin
($152.8)
71.9%
R & D
($18.0)
8.5%
Other
($41.0)
19.3%
Net Earnings
($43.8)
(20.6%)
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
